Allmed Solutions Ltd (ALMD.TA)
ILA 36.8
(-0.54%)
ILA 36.8
(-0.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 5.54 Million | 9.71 Million | 11.14 Million | 9.27 Million |
| Cost of Revenue | - | - | 2.46 Million | 4.34 Million | 6.91 Million | 6.09 Million |
| Gross Profit | - | - | 3.08 Million | 5.37 Million | 4.23 Million | 3.18 Million |
| Operating Expenses | 3.34 Million | 12.29 Million | -3.15 Million | 11.29 Million | -17.85 Million | 26.1 Million |
| Selling, General and Administrative Expenses | 5.43 Million | 2.55 Million | 2.48 Million | 4.37 Million | 6.39 Million | 5.58 Million |
| Research and Development Expenses | 6.64 Million | 359 Thousand | 59 Thousand | 6.92 Million | 12.2 Million | 273 Thousand |
| Other Expenses | -8.72 Million | 9.37 Million | -5.69 Million | 2000.00 | -36.45 Million | 196 Thousand |
| Cost and Expenses | 3.34 Million | 12.29 Million | -694 Thousand | 15.64 Million | -10.93 Million | 32.2 Million |
| Operating Income | -3.34 Million | -12.4 Million | 4.05 Million | -5.92 Million | 22.08 Million | -22.92 Million |
| Interest Expense | - | 46 Thousand | 96 Thousand | 207 Thousand | 248 Thousand | 75 Thousand |
| Income Tax Expense | - | -947 Thousand | 1.24 Million | 1.64 Million | -621 Thousand | 2.51 Million |
| Earnings before Tax | 1.42 Million | -12.14 Million | 2.7 Million | -9.24 Million | 21.38 Million | -20.48 Million |
| Net Income | 1.42 Million | -11.19 Million | 1.45 Million | -10.89 Million | 21.98 Million | -20.17 Million |
| Earnings Per Share Basic | 12.71 | -129.08 | 18.73 | -119.65 | 309.34 | -264.53 |
| Earnings Per Share Diluted | 12.71 | -127.41 | 18.73 | -119.65 | 309.34 | -264.53 |
| Weighted Average Shares Outstanding | 111.83 Thousand | 86.71 Thousand | 77.79 Thousand | 91.04 Thousand | 71.08 Thousand | 76.26 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 111.83 Thousand | 87.84 Thousand | 77.79 Thousand | 91.04 Thousand | 71.08 Thousand | 76.26 Thousand |
| Gross Margin | - | - | 0.56 | 0.55 | 0.38 | 0.34 |
| EBIT Margin | - | - | 0.92 | -0.53 | 2.16 | -1.96 |
| Profit Margin | - | - | 0.26 | -1.12 | 1.97 | -2.17 |
| EBITDA | -10.69 Million | -12.49 Million | -7.89 Million | -7.95 Million | 24.04 Million | -18.41 Million |
| Earnings Before Tax Margin | - | - | 0.73 | -0.61 | 1.98 | -2.47 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | 240 Thousand |
| Gross Profit | - | - | - | - | - | -240 Thousand |
| Operating Expenses | 2710.00 | 2710.00 | 4812.50 | 249 Thousand | 2928.00 | 2803.50 |
| Selling, General and Administrative Expenses | 1376.00 | 1376.00 | 1436.00 | - | 1436.00 | 1279.00 |
| Research and Development Expenses | 1334.00 | 1334.00 | 2008.50 | - | 2008.50 | 1312.50 |
| Other Expenses | - | - | 1368.00 | - | - | - |
| Cost and Expenses | 2710.00 | 2710.00 | 4812.50 | 249 Thousand | 2928.00 | 2803.50 |
| Operating Income | -2710.00 | -2710.00 | -4812.50 | -10.85 Million | -8567.00 | 3140.50 |
| Interest Expense | - | - | - | - | - | 48 Thousand |
| Income Tax Expense | - | - | -3754.50 | - | - | 674 Thousand |
| Earnings before Tax | -1692.00 | -1692.00 | -5091.00 | 1.42 Million | -5091.00 | 5802.00 |
| Net Income | -1692.00 | -1692.00 | -5091.00 | 1.42 Million | -5091.00 | 5802.00 |
| Earnings Per Share Basic | -0.02 | -0.02 | -0.05 | - | -0.05 | 0.06 |
| Earnings Per Share Diluted | -0.02 | -0.02 | -0.05 | - | -0.05 | 0.06 |
| Weighted Average Shares Outstanding | 112.8 Thousand | 112.8 Thousand | 110.87 Thousand | 108.18 Million | 110.87 Thousand | 105.49 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 112.8 Thousand | 112.8 Thousand | 110.87 Thousand | 108.18 Million | 110.87 Thousand | 105.49 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2573.50 | -2573.50 | -8528.50 | - | -8501.33 | 3260.50 |
| Earnings Before Tax Margin | - | - | - | - | - | - |
2915
3317
FGT
2102
BEBE
BGFD